Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator
Authors
Keywords
Lipoprotein(a), Apolipoprotein(a), LDL, Cardiovascular disease, Coronary heart disease, Atherosclerosis, Inflammation, Thrombosis, Fibrinolysis, Oxidized phospholipids, Clinical chemistry, Risk factors, Niacin, Genetics, Mendelian randomization
Journal
Current Atherosclerosis Reports
Volume 15, Issue 10, Pages -
Publisher
Springer Nature
Online
2013-08-28
DOI
10.1007/s11883-013-0360-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography
- (2013) Maya S. Safarova et al. ATHEROSCLEROSIS SUPPLEMENTS
- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
- (2013) et al. EUROPEAN HEART JOURNAL
- Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children
- (2013) N. A. Goldenberg et al. HAEMATOLOGICA
- Lipoprotein(a): resurrected by genetics
- (2013) F. Kronenberg et al. JOURNAL OF INTERNAL MEDICINE
- Genetic Associations with Valvular Calcification and Aortic Stenosis
- (2013) George Thanassoulis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Can Mediate Degradation of the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1)
- (2013) Maryssa Canuel et al. PLoS One
- Association of Lipoprotein Subfractions and Coronary Artery Calcium In Patient at Intermediate Cardiovascular Risk
- (2012) Borut Jug et al. AMERICAN JOURNAL OF CARDIOLOGY
- Two Rare Variants Explain Association with Acute Myocardial Infarction in an Extended Genomic Region Including the Apolipoprotein(A) Gene
- (2012) Werner Koch et al. ANNALS OF HUMAN GENETICS
- Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis
- (2012) Pia R. Kamstrup et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- FGF19 Signaling Cascade Suppresses APOA Gene Expression
- (2012) Indumathi Chennamsetty et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery Disease
- (2012) Deepti Gurdasani et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Associations between serum lipoprotein(a) levels and the severity of coronary and aortic atherosclerosis
- (2012) Yukihiko Momiyama et al. ATHEROSCLEROSIS
- In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a)
- (2012) Michael E. Frischmann et al. ATHEROSCLEROSIS
- Cost-Effectiveness Model of Use of Genetic Testing as an Aid in Assessing the Likely Benefit of Aspirin Therapy for Primary Prevention of Cardiovascular Disease
- (2012) Dov Shiffman et al. CLINICAL THERAPEUTICS
- Lipoprotein(a)
- (2012) Joseph B. Dubé et al. CURRENT OPINION IN LIPIDOLOGY
- Emerging therapeutic agents to lower lipoprotein (a) levels
- (2012) Brian Kolski et al. CURRENT OPINION IN LIPIDOLOGY
- Antisense oligonucleotides for the treatment of dyslipidaemia
- (2012) Maartje E. Visser et al. EUROPEAN HEART JOURNAL
- Lipoprotein (a) is independently correlated with coronary artery calcification
- (2012) Martin Greif et al. European Journal of Internal Medicine
- Lipid-Related Markers and Cardiovascular Disease Prediction
- (2012) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions
- (2012) Rogier A. van Dijk et al. JOURNAL OF LIPID RESEARCH
- Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
- (2012) Harshal A. Deshmukh et al. JOURNAL OF LIPID RESEARCH
- The PCSK9 decade
- (2012) Gilles Lambert et al. JOURNAL OF LIPID RESEARCH
- Nicotinic acid inhibits hepaticAPOAgene expression: studies in humans and in transgenic mice
- (2012) Indumathi Chennamsetty et al. JOURNAL OF LIPID RESEARCH
- What Is the Role of Advanced Lipoprotein Analysis in Practice?
- (2012) Jennifer G. Robinson JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease
- (2012) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism
- (2012) Anna Helgadottir et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lack of association between four SNPs in the SLC22A3-LPAL2-LPA gene cluster and coronary artery disease in a Chinese Han population: a case control study
- (2012) Xiaofei Lv et al. Lipids in Health and Disease
- Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
- (2012) Evan A. Stein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events
- (2011) Adam Taleb et al. Biomarkers in Medicine
- Genetic Variants in the Apolipoprotein(a) Gene and Coronary Heart Disease
- (2011) Yonghong Li et al. Circulation-Cardiovascular Genetics
- Atorvastatin decreases lipoprotein(a): A meta-analysis of randomized trials
- (2011) Hisato Takagi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol
- (2011) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Farnesoid X receptor represses hepatic human APOA gene expression
- (2011) Indumathi Chennamsetty et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
- (2011) Michael H. Davidson et al. Journal of Clinical Lipidology
- Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism
- (2011) Matthew Konerman et al. Journal of Clinical Lipidology
- Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure
- (2011) Guoqing Cao et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein(a): Genotype–Phenotype Relationship and Impact on Atherogenic Risk
- (2011) Byambaa Enkhmaa et al. Metabolic Syndrome and Related Disorders
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum Stress
- (2010) Tracie A. Seimon et al. Cell Metabolism
- Lipoprotein(a) as a cardiovascular risk factor: current status
- (2010) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a) is strongly associated with coronary artery calcification in type-2 diabetic women
- (2010) Atif N. Qasim et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Management of Lp(a)
- (2010) W. Virgil Brown et al. Journal of Clinical Lipidology
- Oxidation-Specific Biomarkers, Lipoprotein(a), and Risk of Fatal and Nonfatal Coronary Events
- (2010) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apolipoprotein(a) Isoforms and the Risk of Vascular Disease
- (2010) Sebhat Erqou et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
- (2010) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Variation in LPAL2 , LPA , and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk
- (2010) James Ronald et al. STROKE
- Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors
- (2009) Sotirios Tsimikas et al. CIRCULATION
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events
- (2009) Beate R Jaeger et al. Nature Reviews Cardiology
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niacin and Lipoprotein(a): Facts, Uncertainties, and Clinical Considerations
- (2008) Angelo M. Scanu et al. AMERICAN JOURNAL OF CARDIOLOGY
- Mechanism of Action of Niacin
- (2008) Vaijinath S. Kamanna et al. AMERICAN JOURNAL OF CARDIOLOGY
- Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy
- (2008) Daniel I. Chasman et al. ATHEROSCLEROSIS
- A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
- (2008) Claes Bergmark et al. JOURNAL OF LIPID RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation